ArticleThe Lancet. Rheumatology2023

Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial.

Andrew L Mammen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.